Status:
COMPLETED
Evaluation of Sleep Apnea Related Inflammation With CRP, ESR and Neutrophil toLymphocyte Ratio
Lead Sponsor:
Ordu University
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
18-65 years
Brief Summary
There is some evidence suggesting that OSA is associated with low level of systemic inflammation and oxidative stress. Low level systemic inflammation and subsequent vascular damage has been implicate...
Eligibility Criteria
Inclusion
- Subjects who were referred for polysomnography (PSG) testing and performed the test were included
Exclusion
- Patients with malignancy, diabetes mellitus, dyslipidemia, cardiovascular disease or hypertension, chronic inflammatory processes, thyroid dysfunction, chronic hepatic disease, renal failure, any acute- subacute infectious disease within past 2 months, if data are incomplete such as blood sample testing results, if they were unable to perform complete PSG testing.
- \-
Key Trial Info
Start Date :
November 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
279 Patients enrolled
Trial Details
Trial ID
NCT02272608
Start Date
November 1 2012
End Date
August 1 2014
Last Update
October 23 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.